(Reuters) -Bayer was ordered on Friday to pay $2.25 billion to a Pennsylvania man who said he developed cancer from exposure to the company's Roundup weedkiller, the man's attorneys said. A jury in the Philadelphia Court of Common Pleas found that John McKivision's non-Hodgkins lymphoma was the result of using Roundup for yard work at his house for a period of several years. The verdict includes $250 million in compensatory damages and $2 billion in punitive damages.

(Reuters) -Bayer was ordered on Friday to pay $2.25 billion to a Pennsylvania man who said he developed cancer from exposure to the company’s Roundup weedkiller, the man’s attorneys said.

A jury in the Philadelphia Court of Common Pleas found that John McKivision’s non-Hodgkins lymphoma was the result of using Roundup for yard work at his house for a period of several years. The verdict includes $250 million in compensatory damages and $2 billion in punitive damages.

“The jury’s punitive damages award sends a clear message that this multi-national corporation needs top to bottom change,” Tom Kline and Jason Itkin, McKivision’s attorneys, said in a joint statement.

  • squiblet@kbin.social
    6·
    11 months ago

    Pretty much that is how it works, yes. Most likely they’d try to pull a J&J and restructure where the debt is given to a subsidiary that then declares bankruptcy. Thankfully that strategy was rejected but they’re still plotting to declare bankruptcy somehow.